Updated:
Auris Health
Auris Health is a Redwood City-based family office investing in growth-stage healthcare, enterprise software, and deep tech.
Auris Health
Auris Health is a medical technology company founded in 2007 in Redwood City, California. It develops robotic micro-surgical devices through integration of robotics, micro-instrumental, endoscopic design, sensing, and data science. Auris Health was acquired by Johnson & Johnson in February 2019 for $5.7 billion.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Redwood City
Corporate office
Redwood City, CA, United States
Frequently asked questions
Who runs investment decisions at Auris Health?
No named investment professionals are publicly associated with Auris Health. The firm does not maintain a website or LinkedIn presence, so the decision-making structure cannot be verified from external sources.
What sectors does Auris Health target?
Based on the limited public profile, Auris Health appears to focus on healthcare technology, enterprise software, and deep tech. Specific sector allocations are not disclosed.
Does Auris Health participate in fund commitments or only direct deals?
Public information does not clarify whether the firm commits to external funds. The available data suggests a focus on direct equity investments and co-investments alongside venture capital funds.
Is Auris Health structured as a single-family office or a multi-family office?
Auris Health is not formally categorized, but its opaque profile is most consistent with a single-family office. No evidence exists of outside capital from other families.
How does Auris Health source proprietary deal flow?
Deal sourcing is not publicly described. Given the firm's lack of public presence, deal flow likely relies on personal networks and relationships with venture firms in the Bay Area.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: